Description
Human IL-6 Antibody (Siltuximab, Research Grade) is a human monoclonal antibody human IgG1 and is produced by our Mammalian expression system.
Product Details
| Item | Details |
| Isotype | Human IgG1 |
| Mol Mass | 49.3&23.1 KDa |
| Formulation Description | Supplied as a 0.2 μm filtered solution of 20 mM Histidine, 8% Sucrose, 0.06% Tween80, pH5.0. |
| Endotoxin | < 1 EU/µg as determined by LAL test. |
| Shipping | The product is shipped on dry ice/polar packs. Upon receipt, store it immediately at the temperature listed below. |
| Storage | Store at ≤ -20℃, stable for 12 months after receipt. Please minimize freeze-thaw cycles. |
Background
Cytokines of the IL6/GCSF/MGF family are glycoproteins of about 170 to 180 amino acid residues that contain four conserved cysteine residues involved in two disulfide bonds. They have a compact, globular fold (similar to other interleukins), stabilized by the 2 disulfide bonds. One half of the structure is dominated by a 4 alpha-helix bundle with a left-handed twist; the helices are anti-parallel, with 2 overhand connections, which fall into a 2-stranded anti-parallel beta-sheet. The fourth alpha helix is important to the biological activity of the molecule. Interleukin-6 (IL-6) is an important proinflammatory and immunoregulatory cytokine expressed by various cells. Interleukin-6 has been shown to inhibit the growth of early stage and to promote the proliferation of advanced stage melanoma cells in vitro.
MDSD